Hematopoietic stem cell heterogeneity and age-associated platelet bias are evolutionarily conserved.
Aksöz M. et al, (2024), Sci Immunol, 9
Selective advantage of mutant stem cells in human clonal hematopoiesis is associated with attenuated response to inflammation and aging.
Jakobsen NA. et al, (2024), Cell Stem Cell
Identification and Age-dependent Increase of Platelet Biased Human Hematopoietic Stem Cells
Aksöz M. et al, (2022)
Single-Cell Analysis of Human Clonal Hematopoiesis Identifies Distinct Impact of DNMT3A and TET2 mutations on Hematopoietic Differentiation
Jakobsen NA. et al, (2022), BLOOD, 140, 2227 - 2228
A phase Ib/II study of ivosidenib with venetoclax plus /- azacitidine in IDH1-mutated myeloid malignancies.
Lachowiez CA. et al, (2021), JOURNAL OF CLINICAL ONCOLOGY, 39
Oncogenic Gata1 causes stage-specific megakaryocyte differentiation delay.
Juban G. et al, (2021), Haematologica, 106, 1106 - 1119
Mechanisms of response and resistance to AML therapies
Stoilova B. et al, (2020), Clinical Lymphoma, Myeloma & Leukemia, 20, S7 - S7
Phase Ib/II study of the IDH1-mutant inhibitor ivosidenib with the BCL2 inhibitor venetoclax plus /- azacitidine in IDH1-mutated hematologic malignancies.
Lachowiez CA. et al, (2020), JOURNAL OF CLINICAL ONCOLOGY, 38
C/EBPalpha and GATA-2 mutations induce bi-lineage acute erythroid leukemia through transformation of a neomorphic neutrophil-erythroid progenitor
NERLOV C. et al, (2020), Cancer Cell
OncogenicGata1causes stage-specific megakaryocyte differentiation delay
Juban G. et al, (2019), Haematologica: the hematology journal
Mechanisms of Progression of Myeloid Preleukemia to Transformed Myeloid Leukemia in Children with Down Syndrome.
Labuhn M. et al, (2019), Cancer cell, 36, 340 - 340
Mechanisms of Progression of Myeloid Preleukemia to Transformed Myeloid Leukemia in Children with Down Syndrome.
Labuhn M. et al, (2019), Cancer Cell, 36, 123 - 138.e10
A Recurrent Activating Missense Mutation in Waldenström Macroglobulinemia Affects the DNA Binding of the ETS Transcription Factor SPI1 and Enhances Proliferation.
Roos-Weil D. et al, (2019), Cancer Discov, 9, 796 - 811
Clonal Heterogeneity of Acute Myeloid Leukemia Treated with the IDH2 inhibitor Enasidenib
Vyas P. et al, (2018), Nature Medicine
Single-cell analysis reveals the continuum of human lympho-myeloid progenitor cells.
Karamitros D. et al, (2018), Nat Immunol, 19, 85 - 97
A Novel Model of Human Hemopoiesis Based on Single Cell Functional and Transcriptional Analysis of Lympho-Myeloid Progenitors
Stoilova B. et al, (2017), BLOOD, 130
Clonal Heterogeneity in Differentiation Response and Resistance to the IDH2 Inhibitor Enasidenib in Acute Myeloid Leukemia
Quek L. et al, (2017), BLOOD, 130